Last week, the EU PAL-COPD consortium convened virtually for its first Supervisory Board meeting. Held on 27 January, this meeting provided an excellent opportunity to review the significant progress made during the first year of the EU PAL-COPD project and to strategise for the upcoming steps toward the randomised controlled trial of the ICLEAR-EU intervention.
The information you provide will only be used for newsletter campaigns by EU PAL-COPD. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp’s terms of use. You can unsubscribe at any time by clicking the link in the footer of our emails. Read our privacy policy to learn how your data is used.
EU PAL-COPD is funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them [grant number 101136621]. This project is also supported by the UK Research and Innovation (UKRI) [grant numbers 10109731 and 10109782], the Ministry of Culture and Innovation of Hungary from the National Research, Development and Innovation Fund [grant number 2020-2.1.1-ED-2023-00260], and the Swiss State Secretariat for Education, Research and Innovation (SERI).
© 2024 accelopment Schweiz AG · info@accelopment.com · ISO 9001 certified · Read our Privacy Policy and Cookie Policy
